Learn why AOD-9604 acetic acid reconstitution matters, how to dissolve the peptide without gelling, and proper storage and dosage basics for research purposes.
AOD-9604 is a synthetic peptide that often requires acetic acid for reconstitution because it does not dissolve well in plain bacteriostatic water. A 0.6% acetic acid solution is typically used to break up the peptide's hydrophobic interactions and prevent the peptide from gelling. This guide explains how to reconstitute AOD-9604 with acetic acid, why gelling happens, and what research dosages and storage conditions look like.
What Is AOD-9604 and Why Use Acetic Acid?
AOD-9604 is a modified fragment of human growth hormone (hGH 176-191) that researchers study for its effects on fat metabolism. The peptide is hydrophobic, meaning it repels water, so it can clump together or form a gel when reconstituted with bacteriostatic water alone.
Acetic acid (typically 0.6% concentration) disrupts those hydrophobic interactions and helps the peptide dissolve into a clear solution. Many vendors ship AOD-9604 as a lyophilized powder and recommend acetic acid as the primary solvent.
Acetic acid is not a drug or a preservative; it is a reconstitution solvent. Once dissolved, the solution can be further diluted with bacteriostatic water to reduce injection site irritation.
How to Reconstitute AOD-9604 with Acetic Acid
Reconstitution should be done slowly and gently to avoid damaging the peptide. The exact volume of acetic acid depends on the vial size and desired concentration.
- Clean the rubber stopper of the AOD-9604 vial with an alcohol swab and let it dry.
- Draw the desired volume of 0.6% acetic acid into a sterile syringe.
- Insert the needle into the vial and aim the stream at the glass wall, not directly at the powder.
- Inject the acetic acid slowly. Do not shake the vial.
- Swirl the vial gently between your palms until the powder dissolves. If it does not dissolve, add a few more drops of acetic acid.
- Once dissolved, you may add bacteriostatic water to dilute the solution if needed for injection comfort.
- Store the reconstituted peptide in the refrigerator at 2°C to 8°C.
Some suppliers provide a how to reconstitute aod 9604 pdf with specific instructions for their product. Always follow the manufacturer's guidance when available.
AOD-9604 Gelling Up: Why It Happens and How to Fix It
A common problem called aod-9604 gelling up occurs when the peptide is reconstituted with too little acetic acid or with plain water. The peptide molecules stick together and form a thick, cloudy gel instead of a clear solution.
Other causes include:
- Using cold solvent or refrigerating the vial before dissolution.
- Shaking the vial aggressively, which can denature the peptide.
- Using a concentration that is too high for the volume of acetic acid.
To fix gelling, add small amounts of 0.6% acetic acid while swirling gently. Warming the vial to room temperature can also help. If the gel persists, the peptide may be degraded and should not be used.
Dosage, Cycle Length, and Frequency in Research
AOD-9604 is not approved for human use, and there is no standard human dosage. Research studies and community protocols often use 250 mcg to 500 mcg per day, injected subcutaneously. A typical aod-9604 5mg dosage might be reconstituted with 1 mL to 3 mL of acetic acid, depending on the desired concentration.
The table below shows common reconstitution volumes for a 5 mg vial and the corresponding volume for a 300 mcg research dose.
| Acetic acid volume | Final concentration | Volume for 300 mcg dose |
|---|---|---|
| 1 mL | 5 mg/mL | 0.06 mL (6 units on insulin syringe) |
| 2 mL | 2.5 mg/mL | 0.12 mL (12 units) |
| 3 mL | 1.67 mg/mL | 0.18 mL (18 units) |
How often you take AOD-9604 varies by protocol. Many research schedules use once-daily injections, often in the morning or before exercise. Cycle length commonly ranges from 4 to 12 weeks, followed by a break, but no official cycle length exists.
These numbers are for informational purposes only. Anyone considering human use should consult a licensed healthcare professional.
AOD-9604 vs. MOTS-c and Tesamorelin
Researchers often compare AOD-9604 with other metabolic peptides like MOTS-c and tesamorelin. When comparing aod 9604 vs mots-c, the key difference is origin: AOD-9604 is a growth hormone fragment, while MOTS-c is a mitochondrial-derived peptide. Both are studied for metabolic effects, but they act through different pathways.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that is FDA-approved for HIV-associated visceral fat. Some researchers combine aod 9604 with tesamorelin, but stacking peptides increases the risk of unknown interactions and side effects.
| Peptide | Origin | Primary research area | Typical solvent |
|---|---|---|---|
| AOD-9604 | hGH fragment 176-191 | Fat metabolism | 0.6% acetic acid |
| MOTS-c | Mitochondrial-derived peptide | Metabolic regulation | Bacteriostatic water |
| Tesamorelin | GHRH analog | Visceral fat | Bacteriostatic water |
Safety, Storage, and Legal Status
AOD-9604 is not FDA-approved for human use in the United States. It is sold as a research chemical and is not intended for human consumption. The FDA has not evaluated AOD-9604 for safety, efficacy, or purity.
Store lyophilized AOD-9604 powder at -20°C for long-term stability. Reconstituted peptide should be kept at 2°C to 8°C and used within 30 days. Acetic acid can cause injection site irritation, so diluting with bacteriostatic water is common.
If you are considering AOD-9604 for any personal use, consult a healthcare professional first. Self-administering research peptides carries risks including infection, allergic reaction, and unknown long-term effects.
Frequently Asked Questions
How do you reconstitute AOD-9604 with acetic acid?
Reconstitute AOD-9604 by slowly injecting 0.6% acetic acid into the vial, aiming at the glass wall, then swirling gently until dissolved. Do not shake the vial. If the peptide does not dissolve, add a few more drops of acetic acid. Store the reconstituted solution in the refrigerator.
Why does AOD-9604 gel up and how can I prevent it?
AOD-9604 gels up because it is hydrophobic and tends to clump in plain water or when too little acetic acid is used. To prevent gelling, always use 0.6% acetic acid as the primary solvent, add it slowly, and swirl instead of shaking. If a gel forms, add more acetic acid and warm the vial to room temperature.
What is a typical AOD-9604 dosage and cycle length?
Research protocols commonly use 250 mcg to 500 mcg per day, injected subcutaneously. Cycle lengths range from 4 to 12 weeks, often followed by a break. However, AOD-9604 is not FDA-approved for human use, and no standard dosage or cycle length has been established in clinical trials.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.